We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
809
Increased
3,918
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
4401
PUT
Bank of New York Mellon
BNY
$107B
$424K ﹤0.01%
9,600
-7,200
-43% -$338K
OR icon
4402
OR Royalties Inc
OR
$6.2B
$424K ﹤0.01%
40,595
-4,267
-10% -$45.3K
NFBK
4403
DELISTED
Northfield Bancorp
NFBK
$423K ﹤0.01%
27,091
+17,652
+187% +$264K
NGHC
4404
DELISTED
National General Holdings Corp
NGHC
$423K ﹤0.01%
18,410
+13,962
+314% +$333K
UTHR icon
4405
United Therapeutics
UTHR
$23.1B
$422K ﹤0.01%
5,404
-83,944
-94% -$7.85M
DMB
4406
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$196M
$420K ﹤0.01%
31,529
-4,914
-13% -$65.3K
ZYNE
4407
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$420K ﹤0.01%
+31,000
New +$358K
JDD
4408
DELISTED
Nuveen Diversified Dividend and Income Fund
JDD
$420K ﹤0.01%
39,428
-2,513
-6% -$26.6K
SMBK icon
4409
SmartFinancial
SMBK
$888M
$419K ﹤0.01%
19,327
+17,968
+1,322% +$372K
UBS icon
4410
PUT
UBS Group
UBS
$176B
$419K ﹤0.01%
35,337
-81,553
-70% -$999K
CLF icon
4411
PUT
Cleveland-Cliffs
CLF
$6.99B
$417K ﹤0.01%
39,100
PEN icon
4412
Penumbra
PEN
$12.8B
$417K ﹤0.01%
2,605
+565
+28% +$81.6K
PTCT icon
4413
PTC Therapeutics
PTCT
$6.12B
$417K ﹤0.01%
9,267
+411
+5% +$16.2K
NVRO
4414
DELISTED
NEVRO CORP.
NVRO
$417K ﹤0.01%
6,433
-4,140
-39% -$258K
AOK icon
4415
iShares Core Conservative Allocation ETF
AOK
$798M
$416K ﹤0.01%
11,756
+4,379
+59% +$152K
ECL icon
4416
PUT
Ecolab
ECL
$79.9B
$415K ﹤0.01%
2,100
-500
-19% -$93K
HNRG icon
4417
Hallador Energy
HNRG
$696M
$413K ﹤0.01%
73,279
+2,654
+4% +$14.3K
MOV icon
4418
Movado Group
MOV
$841M
$413K ﹤0.01%
15,282
-61,200
-80% -$1.92M
PHYS icon
4419
Sprott Physical Gold
PHYS
$15.7B
$413K ﹤0.01%
36,475
-19,494
-35% -$204K
RDOG icon
4420
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
$413K ﹤0.01%
8,773
-350
-4% -$16.5K
NE
4421
DELISTED
Noble Corporation
NE
$413K ﹤0.01%
220,847
+86,282
+64% +$203K
FCOM icon
4422
Fidelity MSCI Communication Services Index ETF
FCOM
$1.81B
$412K ﹤0.01%
12,425
+6,758
+119% +$224K
PRDO icon
4423
Perdoceo Education
PRDO
$2.12B
$412K ﹤0.01%
21,612
-119,177
-85% -$2.2M
TELL
4424
DELISTED
Tellurian Inc.
TELL
$412K ﹤0.01%
52,458
+21,324
+68% +$190K
MTSC
4425
DELISTED
MTS Systems Corp
MTSC
$412K ﹤0.01%
7,049
+2,896
+70% +$161K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 809 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.